*NEW* - Uncovering the Genetic Underpinnings of Sudden Cardiac Arrest (SCA) in a Multi-Ethnic Southeast Asian Population: a PRECISE-SG100K Genomic Study
12 November 2026
Main Applicant – Dr Lim Shir Lynn, Senior Consultant, Department of Cardiology, National University Heart Centre
Sudden cardiac arrest (SCA) is a life threatening condition affecting >3000 individuals annually in Singapore with survival rates of <10% despite improvements in pre-hospital and in-hospital care. While traditional risk factors explain some susceptibility, genetic factors – including rare inherited mutations and common genetic variants – play important roles that remain poorly understood in Asian populations.
This study leverages the PRECISE-SG100K to identify individuals with SCA by integrating disease registries, cause-of-death data, and electronic health records. We will characterise the genetic architecture of SCA through analysis of both rare pathogenic variants in cardiac genes and common polygenic factors. Our specific focus is on: 1) rare variant discovery: identifying pathogenic variants in SCA-implicated genes in asymptomatic individuals, enabling family-based cascade screening, 2) polygenic risk evaluation: assessing how published polygenic risk scores (PRS) perform in an Asian cohort and whether local adaptation improves prediction, and 3) regulatory and integrative analysis: linking genetic signals to cardiac gene expression and causal pathways.
By characterising the genetics of SCA in Singapore's multi-ethnic population—historically underrepresented in genomic research—we will generate evidence for ancestry-specific risk factors. Findings will inform precision prevention strategies, guide genomic-informed clinical workflows, and support development of equitable, population-specific tools for risk stratification and family screening. This work strengthens Singapore's National Precision Medicine infrastructure and contributes to RIE 2030 priorities in cardiovascular health and multi-ethnic genomic equity.
